Skip to main content
Erschienen in: Community Mental Health Journal 6/2011

01.12.2011 | Original Paper

Barriers to, and Strategies for, Starting a Long Acting Injection Clinic in a Community Mental Health Center

verfasst von: Dawn I. Velligan, Elisa Medellin, Meredith Draper, Natalie Maples, Albana Dassori, Troy A. Moore, Linda Lopez

Erschienen in: Community Mental Health Journal | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

As many as 50% of patients with schizophrenia do not take oral antipsychotic medications as prescribed, yet long acting injections are rarely utilized. Community agencies that serve this population are often over-burdened and poorly funded. There are negative attitudes on the part of both physicians and consumers about injections. Transportation and logistics are often problematic. We describe the unique opportunity provided by the need for bi-weekly or monthly injections to establish a recovery-oriented group around injection visits. Our approach discusses methods and resources to help overcome some of the common barriers by establishing advocates within the agency, establishing necessary infrastructure, providing education for consumers, providers, and staff, sharing information about successful outcomes with clinic staff and working through billing issues. We also recommend public advocacy on the part of the clinic and consumers to work with state funding sources to change regulations that may limit appropriate clinical care.
Literatur
Zurück zum Zitat Adams, C. E., Fenton, M. K., Quraishi, S., & David, A. S. (2001). Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. British Journal of Psychiatry, 179(4), 290–299.PubMedCrossRef Adams, C. E., Fenton, M. K., Quraishi, S., & David, A. S. (2001). Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. British Journal of Psychiatry, 179(4), 290–299.PubMedCrossRef
Zurück zum Zitat Babiker, I. E. (1987). Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism. The Journal of Clinical Psychiatry, 48(3), 94–97.PubMed Babiker, I. E. (1987). Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism. The Journal of Clinical Psychiatry, 48(3), 94–97.PubMed
Zurück zum Zitat Buchannan, R., Kreyenbuhl, J., Kelly, D., Noel, J., Boggs, D., Fischer, B., et al. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 71–93.CrossRef Buchannan, R., Kreyenbuhl, J., Kelly, D., Noel, J., Boggs, D., Fischer, B., et al. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 71–93.CrossRef
Zurück zum Zitat Dall, T. M., Wagner, A., Zhang, Y., Yang, W., Arday, D. R., & Ganatt, C. J. (2010). Outcomes and lessons learned from evaluating TRICARE’s disease management programs. The American Journal of Managed Care, 16(6), 438–446.PubMed Dall, T. M., Wagner, A., Zhang, Y., Yang, W., Arday, D. R., & Ganatt, C. J. (2010). Outcomes and lessons learned from evaluating TRICARE’s disease management programs. The American Journal of Managed Care, 16(6), 438–446.PubMed
Zurück zum Zitat Davis, J. M., Janicak, P. G., Singla, A., & Sharma, R. P. (1993). Maintenance antipsychotic medication. In T. R. E. Barnes (Ed.), Antipsychotic drugs and their side effects (pp. 183–203). New York, NY: Academic Press. Davis, J. M., Janicak, P. G., Singla, A., & Sharma, R. P. (1993). Maintenance antipsychotic medication. In T. R. E. Barnes (Ed.), Antipsychotic drugs and their side effects (pp. 183–203). New York, NY: Academic Press.
Zurück zum Zitat Dolder, C. R., Lacro, J. P., Dunn, L. B., & Jeste, D. V. (2002). Antipsychotic medication adherence: Is there a difference between typical and atypical agents? American Journal of Psychiatry, 159(1), 103–108.PubMedCrossRef Dolder, C. R., Lacro, J. P., Dunn, L. B., & Jeste, D. V. (2002). Antipsychotic medication adherence: Is there a difference between typical and atypical agents? American Journal of Psychiatry, 159(1), 103–108.PubMedCrossRef
Zurück zum Zitat Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., et al. (2004). Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692–699.PubMedCrossRef Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., et al. (2004). Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692–699.PubMedCrossRef
Zurück zum Zitat Glazer, W. M., & Kane, J. M. (1992). Depot neuroleptic therapy: An underutilized treatment option. The Journal of Clinical Psychiatry, 53(12), 426–433.PubMed Glazer, W. M., & Kane, J. M. (1992). Depot neuroleptic therapy: An underutilized treatment option. The Journal of Clinical Psychiatry, 53(12), 426–433.PubMed
Zurück zum Zitat Heres, S., Hamann, J., Kissling, W., & Leucht, S. (2006). Attitudes of psychiatrists toward antipsychotic depot medication. Journal of Clinical Psychiatry, 67(12), 1948.PubMedCrossRef Heres, S., Hamann, J., Kissling, W., & Leucht, S. (2006). Attitudes of psychiatrists toward antipsychotic depot medication. Journal of Clinical Psychiatry, 67(12), 1948.PubMedCrossRef
Zurück zum Zitat Hirsch, S. R., & Barnes, T. R. E. (1995). The clinical treatment of schizophrenia with antipsychotic medications. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia. Oxford: Blackwell. Hirsch, S. R., & Barnes, T. R. E. (1995). The clinical treatment of schizophrenia with antipsychotic medications. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia. Oxford: Blackwell.
Zurück zum Zitat Kane, J. M., Aguglia, E., Altamura, A. C., Gutierrez, J. L. A., Brunello, N., Fleischhacker, W. W., et al. (1998). Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology, 8(1), 55–66.PubMedCrossRef Kane, J. M., Aguglia, E., Altamura, A. C., Gutierrez, J. L. A., Brunello, N., Fleischhacker, W. W., et al. (1998). Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology, 8(1), 55–66.PubMedCrossRef
Zurück zum Zitat Lambert, T., Brennan, A., Castle, D., Kelly, D. L., & Conley, R. R. (2003). Perception of depot antipsychotics by mental health professionals. Journal of Psychiatric Practice, 9(3), 252–260.PubMedCrossRef Lambert, T., Brennan, A., Castle, D., Kelly, D. L., & Conley, R. R. (2003). Perception of depot antipsychotics by mental health professionals. Journal of Psychiatric Practice, 9(3), 252–260.PubMedCrossRef
Zurück zum Zitat Llorca, P. M. (2008). Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Research, 161(2), 235–247.PubMedCrossRef Llorca, P. M. (2008). Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Research, 161(2), 235–247.PubMedCrossRef
Zurück zum Zitat Moller, H. J. (2005). Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot. European Psychiatry, 20(5–6), 379–385.PubMedCrossRef Moller, H. J. (2005). Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot. European Psychiatry, 20(5–6), 379–385.PubMedCrossRef
Zurück zum Zitat Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51(2), 216–222.PubMedCrossRef Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51(2), 216–222.PubMedCrossRef
Zurück zum Zitat Schooler, N. R. (2003). Relapse and rehospitalization: Comparing oral and depot antipsychotics. Journal of Clinical Psychiatry, 64(Suppl 16), 14–17.PubMed Schooler, N. R. (2003). Relapse and rehospitalization: Comparing oral and depot antipsychotics. Journal of Clinical Psychiatry, 64(Suppl 16), 14–17.PubMed
Zurück zum Zitat Velligan, D. I., Diamond, P. M., Lopez, J., Castillo, D. A., Maples, N. J., Lam, F., et al. (2007a). Cognitive adaptation training improves adherence to medication and functional outcome in schizophrenia. Schizophrenia Bulletin, 33(2), 608. Velligan, D. I., Diamond, P. M., Lopez, J., Castillo, D. A., Maples, N. J., Lam, F., et al. (2007a). Cognitive adaptation training improves adherence to medication and functional outcome in schizophrenia. Schizophrenia Bulletin, 33(2), 608.
Zurück zum Zitat Velligan, D. I., Lam, F. Y. W., Ereshefsky, L., & Miller, A. L. (2003). Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services, 54(5), 665–667.PubMedCrossRef Velligan, D. I., Lam, F. Y. W., Ereshefsky, L., & Miller, A. L. (2003). Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services, 54(5), 665–667.PubMedCrossRef
Zurück zum Zitat Velligan, D. I., Wang, M., Diamond, P. M., Glahn, D. C., Castillo, D., Bendle, S., et al. (2007b). Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services, 58(9), 1187–1192.PubMedCrossRef Velligan, D. I., Wang, M., Diamond, P. M., Glahn, D. C., Castillo, D., Bendle, S., et al. (2007b). Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services, 58(9), 1187–1192.PubMedCrossRef
Zurück zum Zitat Velligan, D. I., Weiden, P. J., Sajatovicm, M., Scott, J., Carpenter, D., Ross, R., et al. (2008). The expert consensus guidline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry. Velligan, D. I., Weiden, P. J., Sajatovicm, M., Scott, J., Carpenter, D., Ross, R., et al. (2008). The expert consensus guidline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry.
Zurück zum Zitat Weiden, P. (1995). Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen. Psychiatric Services, 46(10), 1049–1054.PubMed Weiden, P. (1995). Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen. Psychiatric Services, 46(10), 1049–1054.PubMed
Metadaten
Titel
Barriers to, and Strategies for, Starting a Long Acting Injection Clinic in a Community Mental Health Center
verfasst von
Dawn I. Velligan
Elisa Medellin
Meredith Draper
Natalie Maples
Albana Dassori
Troy A. Moore
Linda Lopez
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Community Mental Health Journal / Ausgabe 6/2011
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI
https://doi.org/10.1007/s10597-011-9389-6

Weitere Artikel der Ausgabe 6/2011

Community Mental Health Journal 6/2011 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.